Startups
2023
ENDOLIPID DERMA SL Pioneers in the development of SHBG mimetic peptides with activity for cosmetic applications
Address
Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain
CERCA ownership
Barcelona, Spain
2002
Vall d’Hebron Institut de Recerca (VHIR)
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Technological platform:
We have developed and patented a peptide technology platform designed to develop different peptides that mimic the beneficial effects of SHBG.
Main activity:
Our core business is the research and development of peptides. These peptides are derived from the structure of the protein sex hormone-binding globulin (SHBG) and possess antilipogenic, anti-inflammatory, lipolytic, and antifibrotic properties.
We have developed and patented a peptide technology platform designed to develop different peptides that mimic the beneficial effects of SHBG.
Main activity:
Our core business is the research and development of peptides. These peptides are derived from the structure of the protein sex hormone-binding globulin (SHBG) and possess antilipogenic, anti-inflammatory, lipolytic, and antifibrotic properties.
Product description
Programs:
EDL85: For the treatment of cellulite. Cellulite is a benign physiological peripheral lipodystrophy (BPPL) caused by the growth of fat cells, the formation of fibrosis (scar tissue), and the accumulation of fluid between them. This results in the characteristic dimpled and bumpy appearance of the skin, especially on the thighs, buttocks, abdomen, and arms.
EDL81: For the treatment of cellulite. Cellulite is a benign physiological peripheral lipodystrophy (BPPL) caused by the growth of fat cells, the formation of fibrosis (scar tissue), and the accumulation of fluid between them. This results in the characteristic dimpled and bumpy appearance of the skin, especially on the thighs, buttocks, abdomen, and arms.
EDL58: For anti-inflammatory treatment of the skin. Anti-inflammatory skin treatments are a crucial segment of dermocosmetics and dermatology, designed to relieve, reduce, and prevent skin inflammation. This inflammation, which manifests as redness, swelling, itching, pain, and heat, is a common symptom in many dermatological conditions. Although inflammation is vital for healing, when chronic or excessive, it can damage tissue, accelerate skin aging, and cause significant discomfort.
EDL85: For the treatment of cellulite. Cellulite is a benign physiological peripheral lipodystrophy (BPPL) caused by the growth of fat cells, the formation of fibrosis (scar tissue), and the accumulation of fluid between them. This results in the characteristic dimpled and bumpy appearance of the skin, especially on the thighs, buttocks, abdomen, and arms.
EDL81: For the treatment of cellulite. Cellulite is a benign physiological peripheral lipodystrophy (BPPL) caused by the growth of fat cells, the formation of fibrosis (scar tissue), and the accumulation of fluid between them. This results in the characteristic dimpled and bumpy appearance of the skin, especially on the thighs, buttocks, abdomen, and arms.
EDL58: For anti-inflammatory treatment of the skin. Anti-inflammatory skin treatments are a crucial segment of dermocosmetics and dermatology, designed to relieve, reduce, and prevent skin inflammation. This inflammation, which manifests as redness, swelling, itching, pain, and heat, is a common symptom in many dermatological conditions. Although inflammation is vital for healing, when chronic or excessive, it can damage tissue, accelerate skin aging, and cause significant discomfort.